Condition

Chronic Hypertension

ClinicalTrials.gov condition label

Clinical trials4

Recruiting1

Common interventions8

Lead sponsors shown4

Clinical trials

4 shown

Moms@Home: A Storytelling-based Mobile Health Intervention to Improve Blood Pressure Management in PregnancyNCT06835959 · 2025-05-16

Spironolactone in CKD Enabled by Chlorthalidone: PILOTNCT05222191 · 2022-02-01

Labetalol Versus Magnesium Sulfate (MgSO4) for the Prevention of Eclampsia TrialNCT00293735 · 2015-06-01

To Determine Blood Pressure Interaction Between TC-5214 and Anti-Hypertensive Medications (Calcium Channel Blockers, Beta Blockers, and ACE Inhibitors) in Patients With Chronic HypertensionNCT01403922 · 2011-08-01

Common interventions

ChlorthalidoneDRUG1 Enhanced Standard of CareBEHAVIORAL1 labetalol (seizure prevention)DRUG1 MgSO4 (seizure prevention)DRUG1 Moms@HomeBEHAVIORAL1 PlaceboDRUG1 SpironolactoneDRUG1 TC-5214DRUG1

Leading sponsors

AstraZeneca1 Baylor College of Medicine1 Indiana Institute for Medical Research1 University of Massachusetts, Worcester1

Trial status mix

RECRUITING1

TERMINATED1

UNKNOWN1

WITHDRAWN1

Phase mix

PHASE22

NA1

PHASE11

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.